High Shear Emulsifier is a big concept. Various medical emulsifiers can be broadly called medical emulsifiers, including surgical emulsifiers, nursing emulsifiers, rehabilitation emulsifiers, etc. At present, medical emulsifiers refer to minimally invasive surgical emulsifiers in a narrow sense. Minimally invasive surgery is an inevitable trend in the development of surgical technology. It can achieve surgical operations through tiny wounds or natural cavities in the human body, greatly reducing intraoperative damage and shortening recovery time. Since the 1980s, medical emulsifiers have been developed for many years, but clinical products are still in short supply. The most popular one is the Da Vinci endoscopic surgical emulsifier in the United States. Many countries in the world are also developing emulsifier systems for endoscopic surgery, such as Germany, Italy, Japan, South Korea, Israel, Canada, etc.

Domestic universities such as Harbin Institute of Technology, Tianjin University, and Shanghai Jiaotong University have also conducted relevant research. The endoscopic surgical emulsifier system involves the design of high-precision drive transmission mechanisms for multi-degree-of-freedom manipulators, microsurgical instrument design, low-latency control technology, master-slave operation technology, force feedback technology, etc. It is a typical multidisciplinary complex electromechanical system. More importantly, the surgical emulsification machine is a Class III medical device approved by the regulatory authorities, with strict requirements for clinical safety, reliability, effectiveness and applicability, and production system. In addition to endoscopic surgical emulsification machines, there are many specialized surgical emulsification machines, and their functional requirements vary from department to department.

Since the American da Vinci surgical emulsification machine obtained FDA certification, it has basically monopolized the global surgical emulsification machine market. Many new models are priced at around RMB 30 million per unit in the Chinese market, and high maintenance fees are charged every year, and the price of consumables is also very high. The high cost has widened the distance between patients and emulsification machine-assisted minimally invasive surgery. The reason why the da Vinci surgical emulsification machine has been in a monopoly position for a long time is, on the one hand, because of the high-tech intensity and intellectual property factors of the endoscopic surgical emulsification machine, and on the other hand, because the surgical emulsification machine is a Class III medical device with high registration thresholds and strong supervision. If a product wants to enter the medical market, it must undergo strict type inspection, clinical trials and registration reviews, and strictly control the R&D process, production process and product quality in accordance with the requirements of the quality system.

Therefore, if the surgical emulsification machine really enters the operating room, it will require a lot of manpower and financial support on the premise of sufficient technical accumulation. my country is in the golden period of the development of medical emulsification machines, with good national guiding policies and strong support. Hospitals, doctors, and the public have a high degree of recognition of emulsification machine surgery, and market education has matured, resulting in a huge gap in hospital demand. At the same time, colleges and universities and enterprises have shown great interest in the medical emulsification machine industry, forming a good atmosphere for technology research and development and industrial application. However, the industry is still in its infancy in China, with a large talent gap and an imperfect industrial chain. It requires cooperation from the government, industry, education, scientific research, medicine, physical examination, capital, etc. to achieve large-scale promotion and application of medical emulsification machines at home and abroad.